SCHEMBL2299003

SCHEMBL2299003

Cc1ccc2ccc(C(N)=O)cc2n1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.52
KMT2A Q03164 2/20 0.49
LCK P06239 1/20 0.47
PARP1 P09874 2/20 0.45
KDM4E B2RXH2 2/20 0.43
GLA P06280 1/20 0.43
CHEK2 O96017 1/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
CASP6 P55212 1/20 0.43
JAK2 O60674 1/20 0.42
JAK1 P23458 1/20 0.42
TYK2 P29597 1/20 0.42
JAK3 P52333 1/20 0.42
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15286803 0.87 POLB (0.55) CYP1A2KMT2ALCKPARP1KDM4E
SCHEMBL30163484 0.87 POLB (0.55) CYP1A2KMT2ALCKPARP1KDM4E
SCHEMBL9015187 0.83 CYP1A2 (0.53) CYP1A2KMT2ALMNAMEN1
SCHEMBL6880429 0.83 TDP1 (0.59) CYP1A2KMT2AKDM4EMEN1
SCHEMBL2224282 0.81 TDP1 (0.58) CYP1A2KMT2AKDM4EMEN1
SCHEMBL27503111 0.80 KMT2A (0.48) CYP1A2KMT2ALCKKDM4ECHEK2
Lithium Ion SCHEMBL2224280 0.80 CYP1A2 (0.50) CYP1A2KMT2AMEN1
SCHEMBL19691192 0.79 LCK (0.53) KMT2ALCKPARP1KDM4EGLA
SCHEMBL9945611 0.79 KDM4E (0.51) CYP1A2KMT2ALCKKDM4EGLA
SCHEMBL31435439 0.79 KDM4E (0.51) CYP1A2KMT2ALCKKDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519505-A1 NEW TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF Polichem SA (LU) 2012-11-07 EP disclosed
WO-2011080264-A1 NEW TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM S.A. (LU) 2011-07-07 WO disclosed